Archive for March, 2013
On Tuesday, I told you that the road to wealth was paved by tech.
I told you there was still hope for America – and for your retirement – because of the massive profits that the right high-tech stocks can generate.
And I promised to share with you my “blueprint” for high-tech wealth – the five-part strategy that I use to find these stocks … before they begin their rocketing surges.
Today I’m keeping that promise by sharing the very first component of that strategy.
And it’s a big one.
Just to be sure that I’m absolutely clear – and that you get the maximum benefit from today’s talk – I’m also going to tell you about a great company that fits this description perfectly.
Over the next several weeks, I’ll follow up with the rest of my blueprint – and with additional examples and recommendations, too.
So let’s start down this path to massive wealth … together.
I just read a Page One story in The Wall Street Journal I found so disturbing that I had to send this to you right away.
The story’s main message was that millions of Americans can’t afford to retire.
One statistic said it all: 57% of U.S. workers have less than $25,000 in savings.
To me, that’s just nuts…
After all, America isn’t just the land of opportunity and democratic freedoms – it is the single greatest wealth machine in the history of the human race.
So why are so many Americans struggling right now?
Well, there’ no doubt the Great Recession of 2008 cut a swath through a lot of people’s savings. Millions lost their jobs and had to rob from their savings to just make ends meet. I sincerely hope that didn’t happen to you…
But here’s the thing…
Anyone can learn how to build wealth… And anyone can learn how to turn $25,000 into $250,000.
I’m going to teach you how right here…
My Dad, Clarence “Rob” Robinson, has always been a very tough guy.
He played football in high school, and then again as a U.S. Marine. During a game at Camp Pendleton, an injury put his right knee in a cast. Later, while fighting in Vietnam, his left knee was wounded.
But he refused to let the injuries slow him down.
Now, however, as he approaches his 80th birthday, my Dad has to take action. Next month, he goes in for a knee replacement.
It’s become a pretty common procedure, so I’m not worried about the surgery itself.
But I am a bit concerned about “Super Bugs.”
You know what I’m talking about. Drug-resistant Super Bugs are afflicting hospitals, clinics and patients all across the country.
In fact, I’ll wager that you know of a family member, friend or co-worker who’s dealt with this scary – even terrifying – malady.
For patients, these drug-resistant afflictions are something to fear. But for investors and drugmakers, they represent a $9 billion opportunity.
Robots are getting smarter, faster, more independent, and more valuable – almost by the day.
You can find them today scrubbing floors, assembling cars, even performing hair transplants on human patients. With a new $149 accessory debuting this summer, your smartphone can go to work for you as a robotic pet, babysitter, or even your “personal avatar.” Before long, robots will be roaming the halls of your hospital, providing patient monitoring and beaming your vitals back to the attending physician.
Indeed, robots are making a growing list of industries and businesses more efficient and more productive. The “Robotics Revolution” is unfolding at an almost unbelievably rapid pace right now.
Some of you might find that a little unnerving – especially if you’ve watched “Terminator 3” or “Blade Runner” or “I, Robot” recently…
I urge you instead to see this for the tremendous (and fast-moving) tech profit opportunity it is.
Robotics is about to take off in a big way – for two reasons:
- First, a series of breakthroughs in machine learning is making today’s robots smarter and easier to program.
- Second, and even more important for investors to know about, is a new software service that will let robots join one of the hottest trends in high tech today – “cloud computing.” It promises to help the next generation of advanced robots gain a whole new level of independence and make them lighter, cheaper, and more useful.
Today I want to show you the importance of this second development – and the potential boon for investors.
Let’s go to the cloud.
When Ray Harroun came out of retirement in 1911 to race in the first Indianapolis 500, he made one request: He wanted to ditch the ride-along mechanic that the rules required in order to save weight and give his yellow Marmon Wasp a racing edge.
The Indy organizers balked: The mechanic provided a big measure of safety, they said, acting as a spotter who could watch for cars behind or on either side of the racer.
Harroun bolted a mirror to a bracket on his dashboard, was permitted to race without a mechanic, and won the inaugural Indy race – leading 88 of the 200 laps, the most of anyone.
And the rear-view mirror that Harroun used to gain an advantage in a car race? It’s now standard safety equipment on motor vehicles of all types – meaning it occupies the ranks of devices or substances that were designed to solve one problem, but were later found to solve others just as well.
Today I’m going to share a similar story, and show you how a fluid developed to keep aircraft parts clean or suppress fires is being used to solve one of the biggest computer problems we face today.
And I’m even going to show you how to make money from it.
I was a hard-working journalist in the early 1990s – and the whole Human Genome effort was transforming biotechnology into front-page news – when the Oakland Tribune offered me a job as a financial writer.
When the editor explained that biotechnology would be one of my “beats” … well, I jumped at the chance.
It was one of the best career decisions I ever made.
Biotech was an exciting beat to work … and that was an exciting time to work it. So I immersed myself in my assignments. And that meant that I talked at length with patients, company executives, industry analysts, financiers, top researchers, and senior officials at the U.S. Food and Drug Administration (FDA), the federal agency that approves all new drugs sold in the United States.
A five-part series that I produced about a pioneering therapy for multiple sclerosis generated a lot of accolades and was one of my favorite achievements from the four years I spent on the biotech beat.
But the real benefit was in the insights that I gained, and the lessons I learned.
They’ve paid off for me in a big way through the years.
And now they’re going to pay off for you.
In my note to you on Tuesday, I remarked how many of you readers have lots of questions about investing in exotics, particularly the “miracle material” graphene.
Turns out you aren’t the only ones who want to know more about this exciting new field. My good friend and colleague, William Patalon III, decided to interview me for his excellent advisory service, Private Briefing.
Since this is becoming such a popular topic for investors these days, I thought I would share the full interview with you today. It’s a comprehensive look at the forces driving this sector.
And it contains some background material about me that you probably don’t already know.
Here’s the Private Briefing interview. I hope you enjoy it…
You’ve got a rare opportunity to be a high-tech “wildcatter” – thanks to a new miracle material that is destined to revolutionize just about any industry you can think of.
Medicine and biotechnology … electronics … energy … computers … they’ll each be revolutionized by this new substance.
Doctors will soon use it to create implants that will end brain disease…
Technologists will use it to take the power of 1,000 mainframe computers and hardwire it into your smartphone …
And biotechnologists will use this very same substance to work as “synthetic blood.”
I’m talking, of course, about graphene – a substance that I like to refer to as the “miracle material” of the 21st century.
You see, I’ve been following this exotic new substance for some time now and am struck by the high level of interest you readers have in this unique form of graphite (which, of course, is the stuff that’s in the tip of your pencil).
And these days, I get more comments and questions about graphene than I do on any other high-tech topic that I cover.
So today I’m going to tell you about two brand-new breakthroughs that will hasten graphene’s arrival as a commercially viable substance.
And I’m also going to show you how graphene can put profits right into your pocket.
When I first started writing about 3D printing, most investors viewed it as a futuristic “gee-whiz” concept – and had no idea it was actually a “here-and-now” technology they could make money on.
And the mainstream news media didn’t seem to know that this 3D technology even existed.
Today, as you know, many of the 3D stocks (including some that I’ve identified) have soared … and then fallen back to earth. Some pundits claim this was nothing but hype – or another tech bubble that now has burst.
Still others are writing this off as little more than a novelty niche.
Don’t make that mistake.
With 3D printing, we’re in the earliest stages of what’s destined to become an entire new industry.
And, as I’m going to show you today, the profit potential is massive.
And, as I’m going to show you today, the profit potential is massive.